Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems
Zhaoshun Jiang, Cong Sun, Zhaohui Yin, Fang Zhou, Linfu Ge, Ximin Liu, Fansheng KongGeneral Hospital of Ji’nan Command, PLA, Ji'nan, Shandong, ChinaBackground: The applications of ligand-polyethylene glycol (PEG)-modified nanocarriers have now emerged, as well as recognized...
Guardado en:
Autores principales: | Jiang Z, Sun C, Yin Z, Zhou F, Ge L, Liu X, Kong F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e43d288242224842aa6aa375f7cf724f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mannosylated liposomes for targeted gene delivery
por: Kong F, et al.
Publicado: (2012) -
Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA
por: Shao Z, et al.
Publicado: (2015) -
Nanomedicine engulfed by macrophages for targeted tumor therapy
por: Li S, et al.
Publicado: (2016) -
Nanomedicine in pulmonary delivery
por: Heidi M Mansour, et al.
Publicado: (2009) -
Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy
por: Yu Guo, et al.
Publicado: (2018)